Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) (342120)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Next deadline: Oct 18, 2022 (Letter of inquiry)

Later deadlines: Nov 18, 2022 (Full proposal), Feb 15, 2023 (Letter of inquiry), Mar 15, 2023 (Full proposal), Jun 12, 2023 (Letter of inquiry), Jul 12, 2023 (Full proposal)

Grant amount: Up to US $2,325,000

Fields of work: Pharmacology Rare Diseases

Applicant type: For-Profit Business

Funding uses: Research

Location of project: United States

Location of residency: United States


The purpose of this Funding Opportunity Announcement (FOA) is to support basket clinical trials of drugs targeting shared molecular etiologies in more than one rare disease. To facilitate clinical trial start up, and leverage existing datasets, preference will be given to applications focusing on diseases that are under study by the Rare Disease Clinical Research Network (RDCRN), and that involve collaborations with RDCRN clinical investigators.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed July 14, 2022 and last updated July 14, 2022